ESTRO 2022 | Highlights in breast and gynecological cancer at ESTRO 2022

Pedro Lara • 17 May 2022

Breast Cancer Gynecological Cancer

Pedro Lara, MD, PhD, Fernando Pessoa Canarias University and San Roque University Hospital, Gran Canarias, Spain, discusses what he thought were two key presentations at ESTRO 2022 in breast and gynecological cancers. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.

The importance of Patient Reported Outcomes in clinical trials

Pedro Lara • 16 May 2022

How can we optimise the use of patient reported outcomes in clinical practice?

Pedro Lara • 16 May 2022

Related Videos

Evolution, not revolution: the acceptance of biosimilars by practicing clinicians

Mark Pegram • 22 Sep 2017

How to manage elderly patients on immunotherapy

Matti Aapro • 18 Jan 2019

Determining the quality of life in long-term survivors of ovarian cancer

Jalid Sehouli • 16 Nov 2018

The treatment of BC brain metastases

Icro Meattini • 24 May 2020